Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition

BRAF V600E colorectal cancers (CRC) are insensitive to RAF inhibitor monotherapy due to feedback reactivation of receptor tyrosine kinase signaling. Combined RAF and EGFR inhibition exerts a therapeutic effect, but resistance invariably develops through undefined mechanisms. In this study, we determ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Yaeger, Rona, Yao, Zhan, Hyman, David M., Hechtman, Jaclyn F., Vakiani, Efsevia, Zhao, HuiYong, Su, Wenjing, Wang, Lu, Joelson, Andrew, Cercek, Andrea, Baselga, Jose, de Stanchina, Elisa, Saltz, Leonard, Berger, Michael F., Solit, David B., Rosen, Neal
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5712250/
https://ncbi.nlm.nih.gov/pubmed/28951457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-0768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados